Literature DB >> 21221996

Identification of signal peptide domain SOST mutations in autosomal dominant craniodiaphyseal dysplasia.

Su Jin Kim1, Tadeusz Bieganski, Young Bae Sohn, Kazimierz Kozlowski, Mikhail Semënov, Nobuhiko Okamoto, Chi Hwa Kim, Ah-Ra Ko, Geung Hwan Ahn, Yoon-La Choi, Sung Won Park, Chang-Seok Ki, Ok-Hwa Kim, Gen Nishimura, Sheila Unger, Andrea Superti-Furga, Dong-Kyu Jin.   

Abstract

Sclerosteosis and Van Buchem disease are related recessive sclerosing bone dysplasias caused by alterations in the SOST gene. We tested the hypothesis that craniodiaphyseal dysplasia (CDD) (MIM 122860), an extremely rare sclerosing bone dysplasia resulting facial distortion referred to as "leontiasis ossea", could also be caused by SOST mutations. We discovered mutations c.61G>A (Val21Met) and c.61G>T (Val21Leu) two children with CDD. As these mutations are located in the secretion signal of the SOST gene, we tested their effect on secretion by transfecting the mutant constructs into 293E cells. Intriguingly, these mutations greatly reduced the secretion of SOST. We conclude that CDD, the most severe form of sclerotic bone disease, is part of a spectrum of disease caused by mutations in SOST. Unlike the other SOST-related conditions, sclerosteosis and Van Buchem disease that are inherited as recessive traits seem to be caused by a dominant negative mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221996     DOI: 10.1007/s00439-011-0947-3

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  22 in total

1.  Craniodiaphyseal dysplasia.

Authors:  I Kaitila; R E Stewart; E Landow; R Lachman; D L Rimoin
Journal:  Birth Defects Orig Artic Ser       Date:  1975

Review 2.  Craniodiaphyseal dysplasia.

Authors:  L A Brueton; R M Winter
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

3.  Craniodiaphyseal dysplasia: an unusual cause of recurrent dacryocystitis.

Authors:  G Shivanand; H Kandpal
Journal:  Indian J Ophthalmol       Date:  2007 May-Jun       Impact factor: 1.848

4.  Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.

Authors:  W Balemans; J Van Den Ende; A Freire Paes-Alves; F G Dikkers; P J Willems; F Vanhoenacker; N de Almeida-Melo; C F Alves; C A Stratakis; S C Hill; W Van Hul
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

5.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein.

Authors:  M E Brunkow; J C Gardner; J Van Ness; B W Paeper; B R Kovacevich; S Proll; J E Skonier; L Zhao; P J Sabo; Y Fu; R S Alisch; L Gillett; T Colbert; P Tacconi; D Galas; H Hamersma; P Beighton; J Mulligan
Journal:  Am J Hum Genet       Date:  2001-02-09       Impact factor: 11.025

6.  A known SOST gene mutation causes sclerosteosis in a familial and an isolated case from Brazilian origin.

Authors:  Chong Ae Kim; Rachel Honjo; Débora Bertola; Lílian Albano; Luiz Oliveira; Sumatra Jales; José Siqueira; Arthur Castilho; Wendy Balemans; Elke Piters; Karen Jennes; Wim Van Hul
Journal:  Genet Test       Date:  2008-12

7.  The syndromic status of sclerosteosis and van Buchem disease.

Authors:  P Beighton; A Barnard; H Hamersma; A van der Wouden
Journal:  Clin Genet       Date:  1984-02       Impact factor: 4.438

8.  Inherited disorders in the Afrikaner population of southern Africa. Part II. Skeletal, dermal and haematological conditions; the Afrikaners of Gamkaskloof; demographic considerations.

Authors:  M C Botha; P Beighton
Journal:  S Afr Med J       Date:  1983-10-15

9.  Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.

Authors:  May Kung Sutherland; James C Geoghegan; Changpu Yu; Eileen Turcott; John E Skonier; David G Winkler; John A Latham
Journal:  Bone       Date:  2004-10       Impact factor: 4.398

10.  A boy with severe craniodiaphyseal dysplasia and apparently normal mother.

Authors:  Tadeusz Bieganski; Dobromila Baranska; Irmina Miastkowska; Artur Kobielski; Magdalena Gorska-Chrzastek; Kazimierz Kozlowski
Journal:  Am J Med Genet A       Date:  2007-10-15       Impact factor: 2.802

View more
  20 in total

Review 1.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Sclerosing bone dysplasias: leads toward novel osteoporosis treatments.

Authors:  Igor Fijalkowski; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 3.  Role and mechanism of action of sclerostin in bone.

Authors:  Jesus Delgado-Calle; Amy Y Sato; Teresita Bellido
Journal:  Bone       Date:  2016-10-12       Impact factor: 4.398

4.  Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.

Authors:  Ming-Kang Chang; Ina Kramer; Thomas Huber; Bernd Kinzel; Sabine Guth-Gundel; Olivier Leupin; Michaela Kneissel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

Review 5.  Human Genetics of Sclerosing Bone Disorders.

Authors:  Raphaël De Ridder; Eveline Boudin; Geert Mortier; Wim Van Hul
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 6.  The Role of the Osteocyte in Bone and Nonbone Disease.

Authors:  Lynda F Bonewald
Journal:  Endocrinol Metab Clin North Am       Date:  2016-12-12       Impact factor: 4.741

Review 7.  Osteocytic signalling pathways as therapeutic targets for bone fragility.

Authors:  Lilian I Plotkin; Teresita Bellido
Journal:  Nat Rev Endocrinol       Date:  2016-05-27       Impact factor: 43.330

Review 8.  WNT signaling in bone homeostasis and disease: from human mutations to treatments.

Authors:  Roland Baron; Michaela Kneissel
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

Review 9.  Wnt and the Wnt signaling pathway in bone development and disease.

Authors:  Yiping Wang; Yi-Ping Li; Christie Paulson; Jian-Zhong Shao; Xiaoling Zhang; Mengrui Wu; Wei Chen
Journal:  Front Biosci (Landmark Ed)       Date:  2014-01-01

10.  Fractures in connection with an atypical form of craniodiaphyseal dysplasia: case report of a boy and his mother.

Authors:  Ali Al Kaissi; Robert Csepan; Jochen G Hofstaetter; Klaus Klaushofer; Rudolf Ganger; Franz Grill
Journal:  Clinics (Sao Paulo)       Date:  2012-12       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.